Injectable Drug Delivery Market to touch US$ 624.5 Billion By 2022

New York, August 09, 2018: The scope of the report includes a detailed study of global and regional markets on Global Injectable Drug Delivery Market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Baxter International (U.S.), Pfizer (U.S.), Gerresheimer AG (Germany), Becton, Dickinson and Company (U.S.), Schott AG (Germany), Eli Lilly and Company (U.S.), and Terumo Corporation (Japan). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Global Injectable Drug Delivery Market is expected to exceed more than US$ 624.5 Billion by 2022 at a CAGR of 11.5% in the given forecast period.

Creating delivery devices for injectable drugs has been one of the Challenging task of today. As great number of innovation oriented advancements have occurred in the biologics market, which additionally increases the applicability of the injectable devices in the complex disease areas. The expansion in number of chronic illnesses like diabetes and cancer has increased the requirement for Injectable drugs delivery. Unlike other conventional methods of drug delivery, injectable allow maximum bioavailability of the pharmaceutical drug as it bypasses the first pass metabolism. With considerable development in mechanical headways, the devices being produced and marketed in order to take into account the particular needs of the patients.

You Can Find Full Report: https://www.marketresearchengine.com/injectable-drug-delivery-market

The Global Injectable Drug Delivery Market has been segmented as below:

The Global Injectable Drug Delivery Market is Segmented on the lines of Usage Pattern Analysis, Formulation Packaging Analysis, Therapeutic Application Analysis, Type Analysis, Site of Administration Analysis, Distribution Channel Analysis, Facility of Use Analysis and Regional Analysis. By Usage Pattern Analysis this market is segmented on the basis of Curative Care, Immunization and Other Usage Pattern. By Formulation Packaging Analysis this market is segmented on the basis of Ampules, Vials, Cartridges and Bottles. By Therapeutic Application Analysis this market is segmented on the basis of Auto-immune diseases, Hormonal Disorders, Orphan Diseases, Oncology and Other Therapeutic Applications. By Type Analysis this market is segmented on the basis of Devices and Formulations.

By Site of Administration Analysis this market is segmented on the basis of Skin, Circulatory/Musculoskeletal, Organs and Central Nervous System. By Distribution Channel Analysis this market is segmented on the basis of Hospitals and Retail Pharmacy Stores. By Facility of Use Analysis this market is segmented on the basis of Hospitals & Clinics, Home Care Settings and Other Facilities of Use. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.

This report provides:

1) An overview of the global market for Global Injectable Drug Delivery Market and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for Global Injectable Drug Delivery Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

The major driving factors of Global Injectable Drug Delivery Market are as follows:

  • Escalation in demand for self- injection devices
  • Increase in number of chronic diseases
  • Biosimilars
  • New Product Launches and Technological Advancements
  • Innovative technological progress
  • Development of the biologics market

The restraining factors of Global Injectable Drug Delivery Market are as follows:

  • Needle stick injuries and infections
  • Product recalls
  • Optional mode of drug delivery

Request Sample Report: https://www.marketresearchengine.com/injectable-drug-delivery-market

Table of Contents

1 INTRODUCTION

1.1 KEY TAKE AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Regulatory Scenario

7 Injectable Drug Delivery Market, By Type

8 Injectable Drug Delivery Market, By Formulation Packaging

9 Injectable Drug Delivery Market, By Therapeutic Application

10 Injectable Drug Delivery Market, By Usage Pattern

11 Injectable Drug Delivery Market, By Site of Administration

12 Injectable Drug Delivery Market, By Distribution Channel

13 Injectable Drug Delivery Market, By Facility of Use

14 Injectable Drug Delivery Market, By Region

15 Competitive Landscape

16 Company Profiles

16.1 Introduction

16.2 Baxter International, Inc.

16.3 Becton, Dickinson and Company

16.4 Gerresheimer AG

16.5 Pfizer, Inc.

16.6 Schott AG

16.7 ELI Lilly and Company

16.8 Sandoz (A Division of Novartis AG)

16.9 Terumo Corporation

16.10 Teva Pharmaceutical Industries Ltd.

 

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: john@marketresearchengine.com

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com/

 

 

 

Source: http://heraldkeeper.com/market/injectable-drug-delivery-market-touch-us-624-5-billion-2022-94976.html

The post Injectable Drug Delivery Market to touch US$ 624.5 Billion By 2022 appeared first on Herald Keeper.